Back to Search Start Over

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 1; peer review: awaiting peer review]

Authors :
Selsabil Daboussi
Samia Essebaa
Samira Mhamdi
Chiraz Aichaouia
Hela Ghedira
Aida Ayadi
Zied Moetemri
Author Affiliations :
<relatesTo>1</relatesTo>Pneumology, Military Hospital of Tunis, Tunis, 1008, Tunisia<br /><relatesTo>2</relatesTo>University of Tunis El Manar, Tunis, Tunisia<br /><relatesTo>3</relatesTo>Hematology, Military Hospital of Tunis, Tunis, 1008, Tunisia<br /><relatesTo>4</relatesTo>Pathology, Abderrahmen Mami Hospital,, Ariana, 2080, Tunisia
Source :
F1000Research. 12:337
Publication Year :
2023
Publisher :
London, UK: F1000 Research Limited, 2023.

Abstract

Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-relapsing and steroid-dependent ICEP was made respectively. Mepolizumab was prescribed to both patients. This treatment resulted in successful long-term disease management with much fewer side effects than a traditional corticosteroid therapy.

Details

ISSN :
20461402
Volume :
12
Database :
F1000Research
Journal :
F1000Research
Notes :
[version 1; peer review: awaiting peer review]
Publication Type :
Academic Journal
Accession number :
edsfor.10.12688.f1000research.130939.1
Document Type :
case-report
Full Text :
https://doi.org/10.12688/f1000research.130939.1